Insulet launches Omnipod 5 in Canada
April 7, 2025
Insulet (Nasdaq:PODD) announced today that it commercially launched the Omnipod 5 automated insulin delivery (AID) system in Canada.
Insulet (Nasdaq:PODD) announced today that it commercially launched the Omnipod 5 automated insulin delivery (AID) system in Canada.
ICU Medical (Nasdaq: ICUI) announced today that it received FDA 510(k) clearance for several new additions to its infusion pump portfolio.
Satio announced today that it completed a Small Business Innovation Research (SBIR) contract for its intradermal drug delivery system.
New research on a cytokine called IL-17 adds to growing evidence that immune molecules can influence behavior during illness.